Breaking News
Sort by:
Top Post
Experimental Cancer Drug May Slow Inflammation Linked to Heart Disease
An experimental drug already tested as a potential treatment for cancer, lung, and Alzheimer’s disease […]
England to Return to Plan A Following the Success of the Booster Programme
The government has today announced that England will fully return to Plan A on Thursday […]
Testing Measures to Ensure Young People Return to Classrooms
All secondary schools have been asked to provide one on-site test for pupils ahead of […]
Nightlife Industry Joins Covid-19 Vaccine Push for Young People
Leading figures of the nightlife industry – including venues Ministry of Sound and Heaven – […]
Almost 100% of People Have Antibodies After Second Vaccine
Imperial College London and Ipsos MORI have today published their latest antibody surveillance report showing, […]
Leading Social Media Platforms Unite to Support COVID-19 Vaccine Drive
Collaboration comes as all adults aged 18 and over invited to get a jab Filters […]
More than 30 Million People Vaccinated with Second Dose
More than 30 million people in the UK have been vaccinated with a second dose […]
60 Million Doses of Covid-19 Vaccine Administered in UK
Around 72% of UK adults have received a first dose of a COVID-19 vaccine, the […]
World-first Covid-19 Vaccine Booster Study Launches in UK
Thousands of volunteers will receive a booster COVID-19 vaccine in a new clinical trial launching […]
Next Phase of Vaccine Roll-Out
The UK is moving into the next phase of the COVID-19 vaccine programme as the […]
- Eloxx Pharmaceuticals Announces Final Data Assessment from Phase 2 Combination Clinical Trial of ELX-02 in Class 1 Cystic Fibrosis Patients Read more
- Verge Genomics Announces Positive Safety and Tolerability Data from the Phase 1 Clinical Trial of VRG50635, a Potential Best-in-Class Therapeutic for All Forms of ALS Read more
- DEM BioPharma Appoints Wendy Young, Ph.D., to Scientific Advisory Board Read more
- Confo Therapeutics Enters into Research Collaboration for GPCR-Targeting Antibody Discovery with AbCellera Read more
- Vyriad Announces Expansion of T-Cell Lymphoma Trial at Mayo Clinic Read more